✦ LIBER ✦

TNF-alpha and its receptors during high dose IFN-alpha2B therapy in patients with chronic hepatitis C

✍ Scribed by A. Kreil; T. Kobryn; W. Jessner; M. Wichlas; A. Gangl; P. Ferenci; M. Peck-Radosavljevic

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fate of antibody to interferon (IFN) in

✍ Guido Antonelli; Gianluigi Giannelli; Maurizio Currenti; Eleonora Simeoni; Miche 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 392 KB

Combination therapy with interferon alph

✍ J. Juszczyk; B. Bolewska; J. Cianciara; J. Jablonska; P. Zaborowski; D. Niedzial 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

A combined therapy with high dose of int

✍ Takashimizu, Shinji; Watanabe, Norihito; Mine, Tetsuya; Matsuzaki, Shohei 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Pegylated interferon alpha-2b (Peg-IFN α

✍ T. Oze; N. Hiramatsu; T. Yakushijin; M. Kurokawa; T. Igura; K. Mochizuki; K. Ima 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

High and low doses of recombinant interf

✍ Ballowe, Tom; Marlowe, Mike; Algozzine, Bob 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 68 KB

The Changes in Quantitative HCV RNA Tite

✍ Myron J. Tong Ph.D.; M.D.; Lawrence M. Blatt Dr. P.H.; M.B.A.; Andrew Conrad Ph. 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 46 KB